An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Adult Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2015
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis; Psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Biogen
- 07 Jun 2012 Actual patient number is 71 according to ClinicalTrials.gov.
- 07 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Mar 2012 Additional location (Australia) added as reported by ClinicalTrials.gov.